The antibacterial activity and enzymatic inactivation of lividomycin, a new aminoglycosidic antibiotic, were studied with 13 strains of Pseudomonas aeruginosa. The minimal inhibitory concentration of lividomycin was 12.5 to 25 jig/ml, and three strains were resistant to high concentrations of lividomycin (more than 200 ,ug/ml). It was found that P. aeruginosa TI-13 and K-11, highly lividomycin-resistant strains of clinical origin, strongly inactivated the drug. The third resistant strain, Km-41/R, was developed in vitro. Unlike the other resistant strains, Km-41/R, was developed in vitro. Unlike the other resistant strains, Km-41/R did not inactivate the drug, indicating that different mechanisms were involved in lividomycin resistance. By use of a cell-free extract from P. aeruginosa TI-13, the inactivation of lividomycin was found to be caused by the formation of a monophosphorylated product of the drug.
Many papers have been presented on the enzymatic inactivation of the aminoglycosidic antibiotics by cell-free extracts obtained from drugresistant strains of Escherichia coli (6, 12, 13, 16-18, 19), Pseudomonas aeruginosa (3, 5, 7, 8, 15) , and Staphylococcus aureus (4) .
Kanamycin is inactivated by two mechanisms responsible for the production of 6-N-acetylkanamycin (17) and 3'-phosphorylkanamycin (5, 7, 15, 16) . Similarly, streptomycin is inactivated by the formation of adenylstreptomycin (18, 19) and phosphorylstreptomycin (8, 13) . We previously reported that lividomycin, a new aminoglycosidic pentasaccharide antibiotic containing 2-deoxystreptamine (11) , is not inactivated by a kanamycin-phosphorylating enzyme extracted from a drug-resistant strain of P. aeruginosa (7) . Recently, we found that lividomycin was inactivated by the cell-free extract prepared from a lividomycin-resistant strain of P. aeruginosa of clinical origin. This Preparation of the S-150 fraction. Crude cell-free extracts, designated as the S-105 fraction, were prepared by a procedure described previously (7) . Protein in the S-105 fraction was determined by the method of Lowry et al. (9) .
Inactivation system. The lividomycin-inactivating reaction was carried out in two systems designated P and A. The P system contained 0.3 ml of the S-105 fraction (about 10 mg of protein/ml), 0.1 ml of 40 mM disodium adenosine triphosphate (ATP), 0.1 ml of creatine phosphate, 0.1 ml of 1.2 mg/ml creatine kinase, 0.1 ml of 1 mm antibiotic, and 0.3 ml of TMK solution [0.1 M tris(hydroxymethyl)aminomethane buffer containing 0.06 M KCl, 0.01 M magnesium acetate, and 0.006 M 2-mercaptoethanol, pH 7.81. The A system contained 0.3 ml of the S-105 fraction, 0.1 ml of 40 mm ATP, 0.1 ml of 2 mm coenzyme A, 0.1 ml of 1 mm antibiotic, and 0.4 ml of TMK solution. The reaction mixture was incubated at 30 C for 1 hr, and then the reaction was stopped by heating at 80 C for 5 min.
Bioassay (containing y-82P-AtP, 35 IACi/ml, or 8-_4C-AtP, 100 ;&Ci/ml), and 30,liters of the S-105 fraction.
After incubation at 30 C for 60 min, 10 pliters of the reaction mixture was spotted on phosphocellulose paper (ca. 1 cm2, Whatman P-81), washed with distilled water, and dried. The paper was counted in a Packard Tri-Carb scintillation counter with a toluenebased fluid.
RESULTS
Inactivation of lividomycin by P. aeruginosa. The antibacterial activity of lividomycin against P. aeruginosa was determined by using 12 strains of clinical origin and a lividomycin-resistant strain, Km-41/R, isolated in this laboratory. As shown in Table 1 , the minimal inhibitory concentration of lividomycin against susceptible strains was 12.5 to 25 ,ug/ml. Three strains were resistant to high concentrations of lividomycin (more than 200 Ag/ml). The inactivation of lividomycin by crude enzyme extracts from these strains was determined in the P and A systems described above. Lividomycin was inactivated by the two resistant strains which had been isolated from clinical specimens (TI-13 and K-il), but the third resistant strain, Km-41/R, did not inactivate the drug in either system. If antibiotic inactivation is caused by phosphorylation and adenylylation, as is the case with strains TI-13 and K-il, both assays would indicate inactivation because ATP is present in both assay systems.
However, if inactivation were to occur by acetylation, then only the results with the A assay system would be positive. When neither assay system gives a positive result, as was the case with strain Km-41 /R, resistance must occur by a mechanism which does not involve phosphorylation, adenylylation, or acetylation.
Some properties of the crude lividomycin- inactivating enzyme. The lividomycin-inactivating enzyme in the S-105 fraction (100 ml) from strain TI-13 was precipitated by ammonium sulfate between 0.33 and 0.66 saturation; the precipitate was dissolved in 50 ml of TMK solution and dialyzed against 2,000 ml of the same solution. This dialyzed solution (7 mg of protein/mi) was used as a crude enzyme preparation. The time course of inactivation is shown in Fig. 2 . Lividomycin was almost completely inactivated by incubation at 30 C for 60 min under the conditions used.
The optimal pH for the inactivating reaction was near pH 7.0 (Fig. 3) ; activity was greatly reduced below pH 6.0 or above pH 8 Complete system....... enzyme will be necessary to resolve this question.
Results obtained on 32p incorporation into lividomycin suggested that the antibiotic was inacdvated by a mechanism involving the phosphorylation of the drug but not by adenylylation (Table 4) . Isolation of inactivated lividomycin. To obtain the inactivated drug, a reaction mixture (pH 7.8) containing 55 ml of the S-105 fraction (7 mg of protein/ml), 1.2 g of ATP-2Na, and 130 mg of lividomycin was incubated at 30 C for 20 hr. The reaction was stopped by heating at 80 C for 5 mi. It was found that the entire quantity of the antibiotic was inactivated. The reaction mixture was adsorbed onto a CM-Sephadex C-25 column (NH4+ form, 15 The infrared spectrum showed a specific absorption band at 965 cm-l (Fig. 4) . Analysis of the primary amino groups indicated that both active and inactivated lividomycin had five primary amino groups. Analytical data for inactivated lividomycin suggest that it is monophosphorylated on one of the nine hydroxyl groups present. DISCUSSION Several 2-deoxystreptamines containing aminoglycosidic antibiotics, including kanamycin, aminodeoxykanamycin, neomycin, paromomycin, and mannosylparomomycin, have a hydroxyl group at the C-3 position of the D-aminoglucose moiety, which is phosphorylated by inactivating enzymes from the strains resistant to these drugs. On the other hand, lividomycin and the gentamicin C antibiotics (2) are known to be devoid of a hydroxyl group at the C-3 position of the D-aminoglucose and are therefore not inactivated by the phosphorylating enzymes inactivating kanamycin, streptomycin, neomycin, and paromomycin (3-6, 12, 13, 15-17, 19) . This difference in chemical structure may be of biological significance (7, 14) .
The present study disclosed that lividomycin was inactivated through phosphorylation by cellfree extracts from lividomycin-resistant strains of P. aeruginosa. Since the drug is not inactivated by the kanamycin-phosphorylating enzyme (7) , the Pseudomonas inactivation is caused by a different enzyme. The optimal pH for lividomycin inactivation (pH 7.0) was different from that for the dihydrostreptomycin-phosphorylating enzyme (pH 10; 8), and the purified dihydrostreptomycin-phosphorylating enzyme could not inac-tivate lividomycin (unpublished data). It was found, furthermore, that strains 99, 137, and 351 strongly inactivated dihydrostreptomycin in a reaction mixture containing ATP and magnesium acetate but caused little inactivation of lividomycin (unpublished data). These results strongly suggest that the lividomycin-phosphorylating enzyme from strain TI-13 is different from both the kanamycin-and dihydrostreptomycin-phosphorylating enzymes. It was also found that 3'-deoxyparomamine (lividamine), a degradation product of lividomycin, was not phosphorylated by the lividomycin-phosphorylating enzyme (unpublished data). The position of the hydroxyl group of lividomycin that is phosphorylated by P. aeruginosa is currently being determined and will be described elsewhere.
It was reported from this laboratory that the gentamicin C complex of antibiotics were inactivated by resistant strains of P. aeruginosa in the presence of acetyl-coenzyme A (10) . These results and those described in the present paper suggest that the biochemical mechanisms of drug resistance are of diverse nature and present important subjects for further studies on the chemical modification of antibacterial agents.
